Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

PROK

ProKidney Corp

Dec 30 • 04:00PM ET

1.75

Dollar change +0.04
Percentage change 2.65	%

Healthcare • Biotechnology • USA • NASD

Peers: FMS DVA OPK NEPH RMTI AKBA MNKD ARDX ADMA PDEX

| Held by: VTI IWM VXF IWO VTWO SCHA IWN SBIO VTWG SCHB

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.56	Insider Own	28.01%	Shs Outstand	127.92M	Perf Week	15.56%
Market Cap	480.76M	Forward P/E	-	EPS next Y	-0.42	Insider Trans	-0.02%	Shs Float	92.13M	Perf Month	-5.68%
Income	-45.61M	PEG	-	EPS next Q	-0.15	Inst Own	43.17%	Short Float	11.14%	Perf Quarter	-9.11%
Sales	0.00M	P/S	-	EPS this Y	-2.23%	Inst Trans	9.55%	Short Ratio	22.04	Perf Half Y	-30.20%
Book/sh	-7.66	P/B	-	EPS next Y	28.54%	ROA	-9.84%	Short Interest	10.26M	Perf Year	-4.12%
Cash/sh	1.48	P/C	1.18	EPS next 5Y	-	ROE	-	52W Range	1.18 - 4.44	Perf YTD	-1.97%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-60.70%	Beta	1.43
Dividend TTM	-	Quick Ratio	17.09	Sales past 5Y	0.00%	Gross Margin	-	52W Low	47.88%	ATR (14)	0.18
Dividend Ex-Date	-	Current Ratio	17.09	EPS Y/Y TTM	4.19%	Oper. Margin	-	RSI (14)	47.86	Volatility	9.70% 11.17%
Employees	163	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	2.00	Target Price	4.80
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	20.36%	Payout	-	Rel Volume	0.64	Prev Close	1.70
Sales Surprise	-	EPS Surprise	-9.72%	Sales Q/Q	-	Earnings	Nov 12 BMO	Avg Volume	465.58K	Price	1.75
SMA20	-5.02%	SMA50	-4.23%	SMA200	-21.15%	Trades		Volume	297,657	Change	2.65%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-30-24	Initiated	JP Morgan	Neutral
Sep-10-24	Initiated	Guggenheim	Buy	$6
Mar-07-24	Resumed	Morgan Stanley	Equal-Weight	$3
Jan-02-24	Downgrade	BofA Securities	Buy → Neutral
Jul-25-23	Initiated	BTIG Research	Buy	$16
Dec-21-22	Initiated	Jefferies	Buy	$15
Nov-10-22	Initiated	Morgan Stanley	Equal-Weight	$13
Oct-18-22	Initiated	UBS	Buy	$18
Oct-14-22	Initiated	Citigroup	Buy	$16
Sep-23-22	Initiated	BofA Securities	Buy	$14
Sep-02-22	Initiated	Evercore ISI	Outperform

Show Previous Ratings

Nov-26-24 07:30AM	ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference (GlobeNewswire)
Nov-12-24 07:30AM	ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting (GlobeNewswire)
Nov-05-24 07:30AM	ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference (GlobeNewswire)
Oct-22-24 07:02PM	Suvretta Capital Management's Strategic Acquisition in ProKidney Corp (GuruFocus.com) -8.11%
Oct-14-24 07:30AM	ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024 (GlobeNewswire)
07:30AM	Loading…
Oct-09-24 07:30AM	ProKidney to Participate in the UBS Virtual Organ Restoration Day (GlobeNewswire)
Sep-04-24 01:33PM	ProKidney drops Phase III CKD study to focus on US market and save up to $175m (Clinical Trials Arena) -9.17%
Sep-03-24 07:30AM	ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel's Registrational Path to Potential Approval in the U.S. (GlobeNewswire)
Aug-27-24 07:30AM	ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire) -7.53%
Aug-09-24 07:00AM	ProKidney Reports Business Updates and Second Quarter 2024 Financial Results (GlobeNewswire)
Jun-27-24 05:52AM	PROK Stock Earnings: ProKidney Reported Results for Q4 2023 (InvestorPlace) +6.61%
Jun-26-24 02:10PM	Hedge Fund and Insider Trading News: Crispin Odey, Boaz Weinstein, Ken Griffin, Greenlight Capital, Eisler Capital, ProKidney Corp (PROK), Essex Property Trust Inc (ESS), and More (Insider Monkey)
Jun-17-24 07:00AM	ProKidney Announces the Closing of $140 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering, Including Exercise of Underwriters' Option (GlobeNewswire) +6.96%
Jun-11-24 09:35PM	ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering (GlobeNewswire) -19.87% +23.55%
07:40AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
04:15PM	Loading…
Jun-10-24 04:15PM	ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering (GlobeNewswire) -5.33%
07:32AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
06:30AM	ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates (GlobeNewswire)
May-29-24 07:00AM	ProKidney to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire) +6.74%
May-21-24 07:00AM	ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024 (GlobeNewswire)
May-10-24 03:43PM	ProKidney Corp Reports First Quarter 2024 Financial Results (GuruFocus.com) +7.66%
01:54PM	PROK Stock Earnings: ProKidney Beats EPS for Q1 2024 (InvestorPlace)
07:48AM	ProKidney Q1 Loss Unchanged From Year Earlier (MT Newswires)
07:00AM	ProKidney Reports Business Updates and First Quarter 2024 Financial Results (GlobeNewswire)
Mar-25-24 06:05AM	ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations (GlobeNewswire)
Mar-21-24 07:49PM	ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire) -6.16%
Feb-29-24 04:05PM	ProKidney to Participate in Jefferies Biotech on the Bay Summit (GlobeNewswire)
Dec-29-23 08:22AM	Chamath Palihapitiya Stocks: 12 Stocks Pumped in the Last 10 Years (Insider Monkey)
Dec-13-23 09:55AM	Here's Why ProKidney Corp. (PROK) Is a Great 'Buy the Bottom' Stock Now (Zacks) +9.60%
Nov-30-23 06:05AM	ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer (GlobeNewswire) -10.16%
06:40AM	Loading…
Nov-24-23 06:40AM	7 Penny Stocks With Low Floats and High Short Interest (InvestorPlace)
Nov-21-23 06:05AM	ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference (GlobeNewswire) +5.68%
Nov-17-23 01:38PM	ProKidney Corp. (NASDAQ:PROK) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-16-23 09:35AM	After Plunging -37.39% in 4 Weeks, Here's Why the Trend Might Reverse for ProKidney Corp. (PROK) (Zacks) -11.51%
Nov-14-23 07:04AM	ProKidney Corp (PROK) Reports Q3 Financial Results: Focus on Chronic Kidney Disease Trials (GuruFocus.com) -5.00%
06:05AM	ProKidney Reports Third Quarter Financial Results (GlobeNewswire)
Nov-13-23 05:02PM	ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT ) for Diabetic CKD and Provides Corporate Updates (GlobeNewswire)
Oct-30-23 04:12PM	ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023 (GlobeNewswire) +12.29%
Oct-17-23 09:35AM	ProKidney Corp. (PROK) Loses -54.93% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) -7.93%
Oct-16-23 02:50PM	Is Chamath Palihapitiya Giving Up on ProKidney (PROK) Stock? (InvestorPlace)
Oct-12-23 03:05PM	Why Shares of ProKidney Were Dropping Thursday (Motley Fool) -31.45%
Sep-06-23 12:14PM	ProKidney confirms it will expand HQ complex, add 50 jobs in Winston-Salem (American City Business Journals)
Sep-05-23 06:05AM	ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-31-23 10:33AM	3 Biotech Stocks Due for a Massive Short Squeeze (InvestorPlace)
Aug-29-23 01:16PM	ProKidney confirmed as company seeking incentives to expand in Forsyth County (American City Business Journals)
Aug-11-23 02:21PM	ProKidney reports $38.8 million loss in Q2 FY2023 as it advances clinical trials and prepares for Greensboro manufacturing expansion (American City Business Journals)
Aug-10-23 04:10PM	ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights (GlobeNewswire)
Jul-18-23 06:05AM	ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC (GlobeNewswire)
Jul-17-23 06:05AM	ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization (GlobeNewswire) +6.65%
Jun-13-23 12:05PM	ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC (GlobeNewswire)
Jun-01-23 04:05PM	ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference (GlobeNewswire) -7.66%
May-11-23 04:01PM	ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights (GlobeNewswire)
May-04-23 06:05AM	ProKidney to Present at the BofA Securities Health Care Conference 2023 (GlobeNewswire)
Apr-25-23 02:00PM	We're Interested To See How ProKidney (NASDAQ:PROK) Uses Its Cash Hoard To Grow (Simply Wall St.) -8.73%
Mar-28-23 04:12PM	ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights (GlobeNewswire) -7.39%
Mar-03-23 06:05AM	ProKidney to Participate in TD Cowens 43rd Annual Health Care Conference (GlobeNewswire)
Jan-11-23 07:48AM	ProKidneys stock jumps 29% (MarketWatch)
Jan-10-23 04:05PM	ProKidney Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT for Late Stage 4 Diabetes-Related Chronic Kidney Disease (GlobeNewswire) +9.57%
Dec-27-22 11:05AM	Chamath Palihapitiya Stocks: 10 Stocks Picked in the Last 10 Years (Insider Monkey) -5.82%
08:46AM	A Look At The Intrinsic Value Of ProKidney Corp. (NASDAQ:PROK) (Simply Wall St.)
Dec-22-22 06:05AM	ProKidney to Present at the J.P. Morgan 41st Annual Healthcare Conference (GlobeNewswire)
Nov-16-22 11:22AM	ProKidney (NASDAQ:PROK) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Nov-14-22 06:05AM	ProKidney Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Nov-11-22 04:05PM	ProKidney to Participate in Upcoming Investor Conferences (GlobeNewswire) +6.85%
Nov-03-22 06:05AM	ProKidney Receives Allowance from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for proact 1 (REGEN-006) and EMA Scientific Advice on Phase 3 Protocols of REACT for Diabetic Chronic Kidney Disease (GlobeNewswire)
Oct-14-22 12:00PM	ProKidney Announces Multiple Abstracts Selected for Presentation at the American Society of Nephrologys Kidney Week 2022 (GlobeNewswire)
Sep-23-22 06:15AM	ProKidney to Present at the Jefferies Cell and Genetic Medicine Summit (GlobeNewswire)
Sep-08-22 06:05AM	ProKidney to Present at the Morgan Stanley 20th Annual Global Healthcare Conference (GlobeNewswire)
Aug-31-22 06:05AM	ProKidney Appoints Glenn Schulman, PharmD, MPH, as Senior Vice President of Investor Relations (GlobeNewswire) +12.28%
Aug-11-22 05:30PM	ProKidney Corp. Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire) +7.55%
10:01AM	ProKidney Strengthens Board of Directors with Appointments of Dr. John M. Maraganore and Jennifer Fox (GlobeNewswire)
Jul-20-22 08:00AM	ProKidney Appoints Kerry Cooper, M.D., as Senior Vice President of Medical Affairs (GlobeNewswire)

ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Weber Darin J.	Chief Regulatory Officer	Sep 19 '24	Sale	2.50	16,412	41,030	103,480	Sep 20 04:44 PM
DARIN J WEBER	Officer	Sep 19 '24	Proposed Sale	2.39	16,412	39,225		Sep 19 04:27 PM
Weber Darin J.	Chief Regulatory Officer	Jul 26 '24	Sale	2.50	826	2,065	119,892	Jul 29 04:02 PM
Control Empresarial de Capital	Add'l Rep. Persons-see Ex.99-1	Jun 11 '24	Buy	2.42	8,264,462	19,999,998	71,560,107	Jun 25 04:06 PM
Weber Darin J.	Chief Regulatory Officer	Jun 18 '24	Sale	2.82	17,238	48,616	120,718	Jun 20 04:03 PM
Legorreta Pablo G.	Director	Jun 13 '24	Buy	2.42	22,617,909	54,735,340	22,617,909	Jun 14 04:05 PM
Weber Darin J.	Chief Regulatory Officer	May 20 '24	Sale	4.08	17,238	70,386	137,956	May 22 07:22 AM
Control Empresarial de Capital	Add'l Rep. Persons-see Ex.99-1	Mar 13 '24	Buy	1.50	50,000	75,090	63,168,645	May 16 08:22 PM
Control Empresarial de Capital	Add'l Rep. Persons-see Ex.99-1	Mar 14 '24	Buy	1.36	50,000	67,925	63,218,645	May 16 08:22 PM
Control Empresarial de Capital	Add'l Rep. Persons-see Ex.99-1	Mar 20 '24	Buy	1.40	33,000	46,111	63,251,645	May 16 08:22 PM
Control Empresarial de Capital	Add'l Rep. Persons-see Ex.99-1	Mar 25 '24	Buy	1.43	30,000	42,954	63,295,645	May 16 08:22 PM
Control Empresarial de Capital	Add'l Rep. Persons-see Ex.99-1	Mar 22 '24	Buy	1.40	14,000	19,586	63,265,645	May 16 08:22 PM
Weber Darin J.	SVP of Regulatory Development	Apr 22 '24	Sale	2.51	16,438	41,315	155,194	Apr 23 04:05 PM
Weber Darin J.	SVP of Regulatory Development	Apr 18 '24	Sale	2.54	800	2,028	171,632	Apr 23 04:05 PM
Weber Darin J.	SVP of Regulatory Development	Apr 16 '24	Sale	2.50	17,238	43,095	172,432	Apr 17 06:57 PM
Weber Darin J.	SVP of Regulatory Development	Apr 12 '24	Sale	1.73	84,103	145,498	189,670	Apr 16 04:54 PM
Weber Darin J.	SVP of Regulatory Development	Apr 01 '24	Sale	1.69	300	507	273,773	Apr 16 04:54 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PROK

ProKidney Corp

Upgrade your FINVIZ experience